✦ LIBER ✦

446 POSTER A phase I study of eribulin mesylate (E7389) in patients with refractory cancers

✍ Scribed by H. Minami; T. Mukohara; S. Nagai; H. Mukai; M. Namiki

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Eribulin mesylate in patients with refra

✍ Toru Mukohara, Shunji Nagai, Hirofumi Mukai, Masayuki Namiki, Hironobu Minami 📂 Article 📅 2011 🏛 Springer US 🌐 English ⚖ 269 KB

A Phase II Study of Eribulin Mesylate (E

✍ Alexander I. Spira; Nicholas O. Iannotti; Michael A. Savin; Marcus Neubauer; Nas 📂 Article 📅 2012 🏛 CIG Media Group, LP. 🌐 English ⚖ 350 KB

Phase III Trials of Eribulin Mesylate (E

✍ Chris Twelves; Javier Cortes; Linda T. Vahdat; Jantien Wanders; Corina Akerele; 📂 Article 📅 2010 🏛 CIG Media Group, LP. 🌐 English ⚖ 200 KB

Eribulin mesylate (halichondrin B analog

✍ Martee L. Hensley; Sara Kravetz; Xiaoyu Jia; Alexia Iasonos; William Tew; Lauren 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 892 KB

417 POSTER Phase I study of E7389/Gemcit

✍ R. Goel; L. Vidal; S. Welch; S. Laurie; L. Siu; D. Jonker; R. Srinivasan; L. Wan 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 59 KB

A phase II study of the halichondrin B a

✍ Daniel J. Renouf, Patricia A. Tang, Pierre Major, Monika K. Krzyzanowska, Bindi 📂 Article 📅 2011 🏛 Springer US 🌐 English ⚖ 115 KB